Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cytomegalovirus Infection

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    December 2017
  1. HALLECK F, Khadzhynov D, Schrezenmeier E, Lehner L, et al
    Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus Disease.
    Transplant Proc. 2017;49:2280-2284.
    PubMed     Text format     Abstract available


    October 2017
  2. KAYA AH, Tekgunduz E, Akpinar S, Batgi H, et al
    Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?
    Transplant Proc. 2017;49:1911-1915.
    PubMed     Text format     Abstract available


  3. FAVI E, Santangelo R, Iesari S, Morandi M, et al
    Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience.
    Transplant Proc. 2017;49:1766-1772.
    PubMed     Text format     Abstract available


    September 2017
  4. ECHENIQUE IA, Beltran D, Ramirez-Ruiz L, Najafian N, et al
    Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
    Transplant Proc. 2017;49:1560-1564.
    PubMed     Text format     Abstract available


    June 2017
  5. BRUMINHENT J, Rotjanapan P, Watcharananan SP
    Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Transplant Proc. 2017;49:1048-1052.
    PubMed     Text format     Abstract available


    May 2017
  6. BRASIL IRC, Custodio-Lima J, Sampaio RL, Pierre AMM, et al
    Pre-emptive Therapy for Cytomegalovirus in Post-transplantation Liver Patients With Donor-Positive/Recipient-Negative Serostatus.
    Transplant Proc. 2017;49:871-873.
    PubMed     Text format     Abstract available


  7. PRETAGOSTINI R, Poli L, Lai Q, Russo G, et al
    Pre-Emptive Therapy for the Treatment of Cytomegalovirus After Kidney Transplantation.
    Transplant Proc. 2017;49:638-641.
    PubMed     Text format     Abstract available


    April 2017
  8. KIR O, Zeytinoglu A, Arda B, Yilmaz M, et al
    Impact of Prophylaxis vs Pre-emptive Approach for Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2017;49:537-540.
    PubMed     Text format     Abstract available


    March 2017
  9. RUAN V, Czer LS, Awad M, Kittleson M, et al
    Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review.
    Transplant Proc. 2017;49:253-259.
    PubMed     Text format     Abstract available


    January 2017
  10. SHI Y, Liu H, Chen XG, Shen ZY, et al
    Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China.
    Transplant Proc. 2017;49:26-31.
    PubMed     Text format     Abstract available


    November 2016
  11. LUNA E, Caravaca F, Ferreira F, Fernandez N, et al
    Effect of Cytomegalovirus Infection on Survival of Older Kidney Transplant Patients (D+/R+): Impact of Valganciclovir Prophylaxis Versus Preemptive Therapy.
    Transplant Proc. 2016;48:2931-2937.
    PubMed     Text format     Abstract available


  12. CARBONE J, Gallego A, Fernandez Yanez J, Sousa I, et al
    Potential Immunomodulatory Role of Specific Anticytomegalovirus Intravenous Immunoglobulin in Heart Recipients.
    Transplant Proc. 2016;48:3027-3029.
    PubMed     Text format     Abstract available


    October 2016
  13. FENG S, Yang J, Wang W, Hu X, et al
    Incidence and Risk Factors for Cytomegalovirus Infection in Patients With Kidney Transplantation: A Single-Center Experience.
    Transplant Proc. 2016;48:2695-2699.
    PubMed     Text format     Abstract available


    July 2016
  14. FAYEK SA, Beshears E, Lieber R, Alvey N, et al
    Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease.
    Transplant Proc. 2016;48:2056-2064.
    PubMed     Text format     Abstract available


    June 2016
  15. TARASEWICZ A, Debska-Slizien A, Rutkowski B
    Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients.
    Transplant Proc. 2016;48:1650-3.
    PubMed     Text format     Abstract available


    May 2016
  16. KANG GW, Hong HL, Lee IH, Ahn KS, et al
    Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report.
    Transplant Proc. 2016;48:1208-11.
    PubMed     Text format     Abstract available


  17. MATSUURA R, Maeda A, Sakai R, Eguchi H, et al
    Human HLA-Ev (147) Expression in Transgenic Animals.
    Transplant Proc. 2016;48:1323-5.
    PubMed     Text format     Abstract available


    April 2016
  18. NAGANUMA T, Takemoto Y, Iwai T, Kuwabara N, et al
    Effects of Granulocyte and Monocyte Adsorptive Apheresis in Renal Transplantation Recipients With Concomitant Cytomegalovirus Infection.
    Transplant Proc. 2016;48:929-32.
    PubMed     Text format     Abstract available


  19. IWAMOTO H, Nakamura Y, Konno O, Tomita K, et al
    Immunosuppressive Therapy for Elderly Kidney Transplant Recipients.
    Transplant Proc. 2016;48:799-801.
    PubMed     Text format     Abstract available


  20. USHIGOME H, Uchida K, Nishimura K, Akioka K, et al
    Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
    Transplant Proc. 2016;48:794-8.
    PubMed     Text format     Abstract available


    March 2016
  21. AMBROSE T, Sharkey LM, Louis-Auguste J, Rutter CS, et al
    Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation.
    Transplant Proc. 2016;48:492-6.
    PubMed     Text format     Abstract available


  22. ARZE S, Arze L, Abecia C
    Post-transplantation Infections in Bolivia.
    Transplant Proc. 2016;48:646-53.
    PubMed     Text format     Abstract available


    October 2015
  23. CHIASAKUL T, Townamchai N, Jutivorakool K, Chancharoenthana W, et al
    Risk Factors of Cytomegalovirus Disease in Kidney Transplant Recipients: A Single-Center Study in Thailand.
    Transplant Proc. 2015;47:2460-4.
    PubMed     Text format     Abstract available


    July 2015
  24. MADI N, Al-Qaser M, Edan R, Al-Nakib W, et al
    Clinical Utility of Viral Load in the Management of Cytomegalovirus Infection in Solid Organ Transplant Patients in Kuwait.
    Transplant Proc. 2015;47:1802-7.
    PubMed     Text format     Abstract available


  25. SANTOS CA, Brennan DC, Olsen MA
    Accuracy of Inpatient International Classification of Diseases, Ninth Revision, Clinical Modification Coding for Cytomegalovirus After Kidney Transplantation.
    Transplant Proc. 2015;47:1772-6.
    PubMed     Text format     Abstract available


    June 2015
  26. YALCI A, Celebi ZK, Ozbas B, Sengezer OL, et al
    Evaluation of Infectious Complications in the First Year After Kidney Transplantation.
    Transplant Proc. 2015;47:1429-32.
    PubMed     Text format     Abstract available


  27. KELES Y, Tekin S, Duzenli M, Yuksel Y, et al
    Post-transplantation Malignancy After Kidney Transplantation in Turkey.
    Transplant Proc. 2015;47:1418-20.
    PubMed     Text format     Abstract available


    May 2015
  28. JAVAD HOSSEINI SM, Nemati E, Behzadian F, Einollahi B, et al
    Evaluation of ganciclovir resistance in cytomegalovirus infection of renal transplant recipients in tehran.
    Transplant Proc. 2015;47:1140-2.
    PubMed     Text format     Abstract available


  29. ESHRAGHI H, Hekmat R
    Which CMV viral load threshold should be defined as CMV infection in kidney transplant patients?
    Transplant Proc. 2015;47:1136-9.
    PubMed     Text format     Abstract available


    January 2015
  30. MILINKOVIC M, Jovicic-Pavlovic S, Lausevic M, Durutovic O, et al
    Epidemic varicella zoster virus reactivation in renal transplant recipients: a case report.
    Transplant Proc. 2015;47:146-50.
    PubMed     Text format     Abstract available


  31. GARCIA-PAJARES F, Santos-Santamarta F, Fernandez-Fontecha E, Sanchez-Ocana R, et al
    Severe anemia, gastric ulcer, pneumonitis and cholangitis in a liver transplant patient: multiple organic dysfunction and one etiology: a case report.
    Transplant Proc. 2015;47:136-8.
    PubMed     Text format     Abstract available


    December 2014
  32. SMITH A, Couvillion R, Zhang R, Killackey M, et al
    Incidence and management of leukopenia/neutropenia in 233 kidney transplant patients following single dose alemtuzumab induction.
    Transplant Proc. 2014;46:3400-4.
    PubMed     Text format     Abstract available


    September 2014
  33. QUAGLIA M, Cena T, Fenoglio R, Musetti C, et al
    Immune function assay (immunknow) drop over first 6 months after renal transplant: a predictor of opportunistic viral infections?
    Transplant Proc. 2014;46:2220-3.
    PubMed     Text format     Abstract available


  34. SILVESTRE C, Furian L, Marson P, Tison T, et al
    Desensitization With Plasmapheresis and Anti-Cd20 for ABO Incompatible Kidney Transplantation From Living Donor: Experience of a Single Center in Italy.
    Transplant Proc. 2014;46:2209-13.
    PubMed     Text format     Abstract available


    July 2014
  35. LAFTAVI MR, Pankewycz O, Gruessner A, Brian M, et al
    Long-term outcomes of pancreas after kidney transplantation in small centers: is it justified?
    Transplant Proc. 2014;46:1920-3.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: